Date Filed | Type | Description |
12/22/2014 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
11/13/2014 |
4
| Parkinson David Ross (Director) has filed a Form 4 on AMBIT BIOSCIENCES CORP
Txns:
| Disposed/sold 7,085 options to buy
@ $6.66, valued at
$47.2k
Disposed/sold 8,000 options to buy
@ $6.33, valued at
$50.6k
|
|
11/12/2014 |
4
| Hasnain Faheem (Director) has filed a Form 4 on AMBIT BIOSCIENCES CORP
Txns:
| Disposed/sold 144,259 options to buy
@ $6, valued at
$865.6k
Disposed/sold 7,085 options to buy
@ $6.66, valued at
$47.2k
Disposed/sold 8,000 options to buy
@ $6.33, valued at
$50.6k
Disposed/sold 20,000 restricted stock units
@ $15, valued at
$300k
Disposed/sold 775 options to buy
@ $600, valued at
$465k
Disposed/sold 62 options to buy
@ $1680, valued at
$104.2k
|
|
11/12/2014 |
4
| Hatfield Jeffrey S. (Director) has filed a Form 4 on AMBIT BIOSCIENCES CORP
Txns:
| Disposed/sold 14,000 options to buy
@ $6.69, valued at
$93.7k
|
|
11/12/2014 |
4
| Fuhrman Alan (CFO) has filed a Form 4 on AMBIT BIOSCIENCES CORP |
11/12/2014 |
4
| FOLETTA MARK G (Director) has filed a Form 4 on AMBIT BIOSCIENCES CORP
Txns:
| Disposed/sold 14,000 options to buy
@ $11.09, valued at
$155.3k
Disposed/sold 8,000 options to buy
@ $6.33, valued at
$50.6k
|
|
11/12/2014 |
4
| MARTINO MICHAEL A (CEO) has filed a Form 4 on AMBIT BIOSCIENCES CORP
Txns:
| Disposed/sold 451,899 options to buy
@ $6, valued at
$2.7M
Disposed/sold 46,083 options to buy
@ $11.81, valued at
$544.2k
Disposed/sold 91,700 options to buy
@ $10.8, valued at
$990.4k
Disposed/sold 253,871 restricted stock units
@ $15, valued at
$3.8M
|
|
11/12/2014 |
4
| North Annette (Senior VP and General Counsel) has filed a Form 4 on AMBIT BIOSCIENCES CORP
Txns:
| Disposed/sold 66,000 options to buy
@ $11.81, valued at
$779.5k
Disposed/sold 40,000 options to buy
@ $10.8, valued at
$432k
Disposed/sold 63,502 restricted stock units
@ $15, valued at
$952.5k
|
|
11/12/2014 |
4
| Countouriotis Athena (Chief Medical Officer) has filed a Form 4 on AMBIT BIOSCIENCES CORP |
09/04/2014 |
4
| ELMS STEVE (Director) has filed a Form 4 on AMBIT BIOSCIENCES CORP
Txns:
| Exercised (in-or-at-the-money) 2,362 shares
@ $6.66, valued at
$15.7k
Exercised (in-or-at-the-money) 2,362 options to buy
@ $6.66, valued at
$15.7k
|
|
07/16/2014 |
4
| Hasnain Faheem (Director) has filed a Form 4 on AMBIT BIOSCIENCES CORP
Txns:
| Granted 20,000 restricted stock units
@ $0 |
|
06/04/2014 |
4
| Hatfield Jeffrey S. (Director) has filed a Form 4 on AMBIT BIOSCIENCES CORP
Txns:
| Granted 14,000 options to buy
@ $6.69, valued at
$93.7k
|
|
05/19/2014 |
4
| North Annette (Senior VP & General Counsel) has filed a Form 4 on AMBIT BIOSCIENCES CORP
Txns:
| Granted 63,502 restricted stock units
@ $0 |
|
05/19/2014 |
4
| Countouriotis Athena (Chief Medical Officer) has filed a Form 4 on AMBIT BIOSCIENCES CORP |
05/19/2014 |
4
| Fuhrman Alan (CFO) has filed a Form 4 on AMBIT BIOSCIENCES CORP |
05/19/2014 |
4
| MARTINO MICHAEL A (President and CEO) has filed a Form 4 on AMBIT BIOSCIENCES CORP
Txns:
| Granted 253,871 restricted stock units
@ $0 |
|
05/16/2014 |
4
| Peimer Isai (Director) has filed a Form 4 on AMBIT BIOSCIENCES CORP
Txns:
| Granted 8,000 options to buy
@ $6.33, valued at
$50.6k
|
|
05/16/2014 |
4
| Parkinson David Ross (Director) has filed a Form 4 on AMBIT BIOSCIENCES CORP
Txns:
| Granted 8,000 options to buy
@ $6.33, valued at
$50.6k
|
|
05/16/2014 |
4
| Marchington Allan P (Director) has filed a Form 4 on AMBIT BIOSCIENCES CORP
Txns:
| Granted 8,000 options to buy
@ $6.33, valued at
$50.6k
|
|
05/16/2014 |
4
| FOLETTA MARK G (Director) has filed a Form 4 on AMBIT BIOSCIENCES CORP
Txns:
| Granted 8,000 options to buy
@ $6.33, valued at
$50.6k
|
|
05/16/2014 |
4
| FLEMING STANDISH (Director) has filed a Form 4 on AMBIT BIOSCIENCES CORP
Txns:
| Granted 8,000 options to buy
@ $6.33, valued at
$50.6k
|
|
05/16/2014 |
4
| ELMS STEVE (Director) has filed a Form 4 on AMBIT BIOSCIENCES CORP
Txns:
| Granted 8,000 options to buy
@ $6.33, valued at
$50.6k
|
|
05/16/2014 |
4
| Bonita David P (Director) has filed a Form 4 on AMBIT BIOSCIENCES CORP
Txns:
| Granted 8,000 options to buy
@ $6.33, valued at
$50.6k
|
|
05/16/2014 |
4
| Hasnain Faheem (Director) has filed a Form 4 on AMBIT BIOSCIENCES CORP
Txns:
| Granted 8,000 options to buy
@ $6.33, valued at
$50.6k
|
|
01/27/2014 |
4
| FOLETTA MARK G (Director) has filed a Form 4 on AMBIT BIOSCIENCES CORP
Txns:
| Granted 14,000 options to buy
@ $11.09, valued at
$155.3k
|
|
01/10/2014 |
4
| North Annette (Senior VP & General Counsel) has filed a Form 4 on AMBIT BIOSCIENCES CORP
Txns:
| Granted 40,000 options to buy
@ $10.8, valued at
$432k
|
|
01/10/2014 |
4
| Fuhrman Alan (CFO) has filed a Form 4 on AMBIT BIOSCIENCES CORP |
01/10/2014 |
4
| MARTINO MICHAEL A (President and CEO) has filed a Form 4 on AMBIT BIOSCIENCES CORP
Txns:
| Granted 91,700 options to buy
@ $10.8, valued at
$990.4k
|
|
01/10/2014 |
4
| Countouriotis Athena (Chief Medical Officer) has filed a Form 4 on AMBIT BIOSCIENCES CORP |
10/16/2013 |
4
| Foresite Capital Management I, LLC (10% Owner) has filed a Form 4 on AMBIT BIOSCIENCES CORP |
10/16/2013 |
3
| Foresite Capital Management I, LLC (10% Owner) has filed a Form 3 on AMBIT BIOSCIENCES CORP |
07/18/2013 |
4
| MARTINO MICHAEL A (President and CEO) has filed a Form 4 on AMBIT BIOSCIENCES CORP
Txns:
| Granted 46,083 options to buy
@ $11.81, valued at
$544.2k
|
|
07/18/2013 |
4
| Countouriotis Athena (Chief Medical Officer) has filed a Form 4 on AMBIT BIOSCIENCES CORP
Txns:
| Granted 76,481 options to buy
@ $11.81, valued at
$903.2k
|
|
07/18/2013 |
4
| Fuhrman Alan (CFO) has filed a Form 4 on AMBIT BIOSCIENCES CORP
Txns:
| Granted 68,369 options to buy
@ $11.81, valued at
$807.4k
|
|
|